// App-Quantinova.ai

1534 : Vimentin prevents a miR-dependent negative regulation of tissue factor mRNA during epithelial-mesenchymal transitions and facilitates early metastasis

Researchers

Presenter

  • Aline Vanwynsberghe

Principal Investigators

  • Marie-Emilie Francart

  • Christine Gilles

Medical Centers

  • University of Liege, Liege, Belgium.

Locations

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

  • Coagulation Factor III, Tissue Factor

  • Vimentin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved